Repro Med Systems (KRMD) Misses Q4 EPS by 4c

Repro Med Systems (NASDAQ: KRMD) reported Q4 EPS of ($0.07), $0.04 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $6.5 million versus the consensus estimate of $6.06 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c